XCUR
Exicure (XCUR)
$88
About Exicure (XCUR)
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.
Details
Daily high
$2.93
Daily low
$2.73
Price at open
$2.73
52 Week High
$9.50
52 Week Low
$1.71
Market cap
17.5M
Dividend yield
0.00%
Volume
17,785
Avg. volume
34,854
P/E ratio
-1.78
Exicure News
Details
Daily high
$2.93
Daily low
$2.73
Price at open
$2.73
52 Week High
$9.50
52 Week Low
$1.71
Market cap
17.5M
Dividend yield
0.00%
Volume
17,785
Avg. volume
34,854
P/E ratio
-1.78